Vein locator included in medical insurance pilot program, reducing patient medical costs

In July 2025, the National Healthcare Security Administration announced that the cost of using vein locators would be included in the medical insurance pilot program in some provinces and cities. For newborns, people over 65 years old, and cancer chemotherapy patients, the reimbursement rate reaches 80%, reducing the economic burden on patients and promoting the widespread use of the device in primary healthcare institutions.